Award

Consultancy Services relating to the design, validation and Qualification of Clean Rooms within Gene Therapy Innovation Manufacturing Centre

UNIVERSITY OF SHEFFIELD

This public procurement record has 4 releases in its history.

TenderUpdate

24 Feb 2022 at 14:19

Award

23 Feb 2022 at 11:55

Award

18 Feb 2022 at 11:48

Award

25 Jan 2022 at 18:18

Summary of the contracting process

The University of Sheffield is currently undertaking a procurement process for consultancy services related to the design, validation, and qualification of clean rooms within its new Gene Therapy Innovation Manufacturing Centre (GTIMC). This project, categorized under construction consultancy services, aims to bolster the clinical development of new genetic treatments. The GTIMC is expected to open in Summer 2022, with work deadlines critically aligned to ensure full completion and necessary regulatory licensing by the end of July 2022. The procurement method being utilized is limited, specifically an award procedure without prior publication of a call for competition, due to the specific technical requirements involved.

This procurement presents significant opportunities for businesses, particularly those with expertise in cell and gene therapy, clean room manufacturing, and related fields. Companies with a strong track record in engaging with regulatory bodies such as the MHRA and experience in delivering similar services in high-pressure environments should consider competing for this contract. The GTIMC's establishment not only enhances the UK's capabilities in gene therapy but also fosters partnerships that may lead to further innovation and research opportunities within the sector.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Consultancy Services relating to the design, validation and Qualification of Clean Rooms within Gene Therapy Innovation Manufacturing Centre

Notice Description

The University of Sheffield (UoS) is establishing a new 'Gene Therapy Innovation Manufacturing Centre' (GTIMC) to advance scientific discoveries into life-changing treatments for patients with life threatening diseases. The Sheffield GTIMC will be one of three cutting edge hubs in the UK dedicated to advancing the clinical development of new genetic treatments. This facility is due to open in the Summer of 2022 and further details can be found at the following link:- https://www.sheffield.ac.uk/news/new-gene-therapy-innovation-centre-advance-scientific-discoveries-life-changing-treatments The services to be procured include the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments including obtaining full MHRA Licence.

Lot Information

Lot 1

Services are required for a number of tasks during the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments in addition to all process areas across the site and supporting site operations such as major infrastructure and support services such as logistics in addition to other areas. These works are to cover the following areas / requirements: Qualification Requirement Matrix prepared to track Validation Lifecycle and to support; MHRA Audit. Used on previous MHRA audits and proved effective; Validation Assessment, User Requirement Specifications, Validation Plan, Design Document Reviews; Vendor Document Reviews, Factory Acceptance Tests Site Acceptance Tests (Commissioning); COTS Installation/Operational Qualification Protocol, Installation Qualification Protocol; Thermal Mapping Protocol (Empty and Loaded), Operational Qualification Protocol; Performance Qualification Protocol, Validation Summary Reports; It is envisaged that the majority of documentation preparation will be carried out remotely from the new build site, however, close working relationships will be required with attendance at site meetings for all aspects of the build and clean room fit outs will be required therefore an estimate of 50% site attendance is anticipated. It will be a requirement that the provider will regularly visit site throughout the construction period to ensure that the build is being documented to a suitable standard to allow for information leveraging into qualification. These visits will also be to ensure that the MHRA are suitably informed throughout all stages of the construction period. Attendance by the provider and being that professional capacity for all engagement with the MHRA will be a major requirement and throughout the Licence application process and to assist the client in this application process through to successfully licence being granted. Major recent experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. As part of the process of validation and qualification, down stream training will be required to be delivered to allow for periodic validation of clean rooms areas by incumbent UoS GTIMC and UoS Estates and Facilities staff. The project has extremely aggressive timelines with build construction due for completion in July 2022 and therefore standing up of this service will be required to be in place during the early stages of February 2022.

Procurement Information

The University of Sheffield signed an agreement with Cell and Gene Therapy Catapult (CGT Catapult) to tech transfer the Catapult AAV (Adeno-Associated Virus) manufacturing platform to Gene Therapy Innovation and Manufacturing Centre' (GTIMC). This task is one of the milestones under the funding award supporting the establishment of the GTIMC in Sheffield. The milestone must be completed within 12 months of the start of the GTIMC Project, i.e. by end July 2022. Any delay in the tech transfer will also impact on the milestone related to MHRA accreditation of GTIMC due by end Q4 2022. The GTIMC and University of Sheffield will jointly acquire a technology license from CGT Catapult to be able to use their AAV manufacturing platform. This platform was established and optimised based on the processes developed using the proposed list of equipment. A single source is therefore proposed to formalise the solution provided by Complete Technical Solutions Ltd for the following reasons: - Significant recent (within the previous 6 months) experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. To increase the U.K. capacity for GMP clinical vector manufacturing using the Catapult process to allow for expansion of U.K. skills and training within the GTIMC space and increase partnerships with other academia which will create a fertile ecosystem for innovation and research excellence in this field across academia.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-030f50
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/005165-2022
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

71 - Architectural, construction, engineering and inspection services


CPV Codes

71530000 - Construction consultancy services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£370,000 £100K-£500K

Notice Dates

Publication Date
24 Feb 20223 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
16 Jan 20224 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
UNIVERSITY OF SHEFFIELD
Contact Name
Jamie Shaw
Contact Email
jamie.shaw@sheffield.ac.uk
Contact Phone
+44 1142221516

Buyer Location

Locality
SHEFFIELD
Postcode
S10 2TN
Post Town
Sheffield
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE3 South Yorkshire
Small Region (ITL 3)
TLE32 Sheffield
Delivery Location
TLE32 Sheffield

Local Authority
Sheffield
Electoral Ward
Broomhill and Sharrow Vale
Westminster Constituency
Sheffield Central

Supplier Information

Number of Suppliers
1
Supplier Name

COMPLETE TECHNICAL SOLUTIONS

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-030f50-2022-02-24T14:19:58Z",
    "date": "2022-02-24T14:19:58Z",
    "ocid": "ocds-h6vhtk-030f50",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-030f50",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Consultancy Services relating to the design, validation and Qualification of Clean Rooms within Gene Therapy Innovation Manufacturing Centre",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "71530000",
            "description": "Construction consultancy services"
        },
        "mainProcurementCategory": "services",
        "description": "The University of Sheffield (UoS) is establishing a new 'Gene Therapy Innovation Manufacturing Centre' (GTIMC) to advance scientific discoveries into life-changing treatments for patients with life threatening diseases. The Sheffield GTIMC will be one of three cutting edge hubs in the UK dedicated to advancing the clinical development of new genetic treatments. This facility is due to open in the Summer of 2022 and further details can be found at the following link:- https://www.sheffield.ac.uk/news/new-gene-therapy-innovation-centre-advance-scientific-discoveries-life-changing-treatments The services to be procured include the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments including obtaining full MHRA Licence.",
        "lots": [
            {
                "id": "1",
                "description": "Services are required for a number of tasks during the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments in addition to all process areas across the site and supporting site operations such as major infrastructure and support services such as logistics in addition to other areas. These works are to cover the following areas / requirements: Qualification Requirement Matrix prepared to track Validation Lifecycle and to support; MHRA Audit. Used on previous MHRA audits and proved effective; Validation Assessment, User Requirement Specifications, Validation Plan, Design Document Reviews; Vendor Document Reviews, Factory Acceptance Tests Site Acceptance Tests (Commissioning); COTS Installation/Operational Qualification Protocol, Installation Qualification Protocol; Thermal Mapping Protocol (Empty and Loaded), Operational Qualification Protocol; Performance Qualification Protocol, Validation Summary Reports; It is envisaged that the majority of documentation preparation will be carried out remotely from the new build site, however, close working relationships will be required with attendance at site meetings for all aspects of the build and clean room fit outs will be required therefore an estimate of 50% site attendance is anticipated. It will be a requirement that the provider will regularly visit site throughout the construction period to ensure that the build is being documented to a suitable standard to allow for information leveraging into qualification. These visits will also be to ensure that the MHRA are suitably informed throughout all stages of the construction period. Attendance by the provider and being that professional capacity for all engagement with the MHRA will be a major requirement and throughout the Licence application process and to assist the client in this application process through to successfully licence being granted. Major recent experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. As part of the process of validation and qualification, down stream training will be required to be delivered to allow for periodic validation of clean rooms areas by incumbent UoS GTIMC and UoS Estates and Facilities staff. The project has extremely aggressive timelines with build construction due for completion in July 2022 and therefore standing up of this service will be required to be in place during the early stages of February 2022.",
                "hasOptions": false,
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKE32"
                    },
                    {
                        "region": "UKE32"
                    },
                    {
                        "region": "UKE32"
                    }
                ],
                "deliveryLocation": {
                    "description": "Gene Therapy Innovation and Manufacturing Centre, Faculty of Medicine Dentistry and Health, The University of Sheffield"
                },
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_TECHNICAL",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons"
            }
        ],
        "procurementMethodRationale": "The University of Sheffield signed an agreement with Cell and Gene Therapy Catapult (CGT Catapult) to tech transfer the Catapult AAV (Adeno-Associated Virus) manufacturing platform to Gene Therapy Innovation and Manufacturing Centre' (GTIMC). This task is one of the milestones under the funding award supporting the establishment of the GTIMC in Sheffield. The milestone must be completed within 12 months of the start of the GTIMC Project, i.e. by end July 2022. Any delay in the tech transfer will also impact on the milestone related to MHRA accreditation of GTIMC due by end Q4 2022. The GTIMC and University of Sheffield will jointly acquire a technology license from CGT Catapult to be able to use their AAV manufacturing platform. This platform was established and optimised based on the processes developed using the proposed list of equipment. A single source is therefore proposed to formalise the solution provided by Complete Technical Solutions Ltd for the following reasons: - Significant recent (within the previous 6 months) experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. To increase the U.K. capacity for GMP clinical vector manufacturing using the Catapult process to allow for expansion of U.K. skills and training within the GTIMC space and increase partnerships with other academia which will create a fertile ecosystem for innovation and research excellence in this field across academia.",
        "amendments": [
            {
                "id": "1",
                "description": "**PLEASE NOTE - THIS CONTRACT AWARD NOTICE WAS ISSUED IN ERROR AND IS A DUPLICATE OF 2022/S 000-004634.**"
            }
        ]
    },
    "awards": [
        {
            "id": "002231-2022-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-41963",
                    "name": "Complete Technical Solutions Limited"
                }
            ]
        },
        {
            "id": "004634-2022-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-41963",
                    "name": "Complete Technical Solutions Limited"
                }
            ]
        },
        {
            "id": "005055-2022-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-41963",
                    "name": "Complete Technical Solutions Limited"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-613",
            "name": "UNIVERSITY OF SHEFFIELD",
            "identifier": {
                "legalName": "UNIVERSITY OF SHEFFIELD"
            },
            "address": {
                "streetAddress": "Western Bank",
                "locality": "SHEFFIELD",
                "region": "UKE32",
                "postalCode": "S102TN",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Jamie Shaw",
                "telephone": "+44 1142221516",
                "email": "jamie.shaw@sheffield.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.sheffield.ac.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "09",
                        "description": "Education"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-41963",
            "name": "Complete Technical Solutions Limited",
            "identifier": {
                "legalName": "Complete Technical Solutions Limited"
            },
            "address": {
                "locality": "Manchester",
                "region": "UKD36",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-41964",
            "name": "High Court of England, Wales & Northern Ireland",
            "identifier": {
                "legalName": "High Court of England, Wales & Northern Ireland"
            },
            "address": {
                "locality": "London",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        },
        {
            "id": "GB-FTS-614",
            "name": "High Court of England, Wales and Northern Ireland",
            "identifier": {
                "legalName": "High Court of England, Wales and Northern Ireland"
            },
            "address": {
                "locality": "London",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-613",
        "name": "UNIVERSITY OF SHEFFIELD"
    },
    "contracts": [
        {
            "id": "002231-2022-1",
            "awardID": "002231-2022-1",
            "status": "active",
            "value": {
                "amount": 370000,
                "currency": "GBP"
            },
            "dateSigned": "2022-01-25T00:00:00Z"
        },
        {
            "id": "004634-2022-1",
            "awardID": "004634-2022-1",
            "status": "active",
            "dateSigned": "2022-01-16T00:00:00Z"
        },
        {
            "id": "005055-2022-1",
            "awardID": "005055-2022-1",
            "status": "active",
            "dateSigned": "2022-01-16T00:00:00Z"
        }
    ],
    "language": "en",
    "bids": {
        "statistics": [
            {
                "id": "3",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "1",
                "measure": "lowestValidBidValue",
                "relatedLot": "1",
                "value": 280125,
                "currency": "GBP"
            },
            {
                "id": "2",
                "measure": "highestValidBidValue",
                "relatedLot": "1",
                "value": 370000,
                "currency": "GBP"
            },
            {
                "id": "6",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "4",
                "measure": "lowestValidBidValue",
                "relatedLot": "1",
                "value": 280124,
                "currency": "GBP"
            },
            {
                "id": "5",
                "measure": "highestValidBidValue",
                "relatedLot": "1",
                "value": 370000,
                "currency": "GBP"
            }
        ]
    }
}